By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Investigators publish new report on Biotechnology. According to news originating from Stockholm, Sweden, by NewsRx correspondents, research stated, "Anti-N-methyl-D-aspartate receptor encephalitis is a severe, potentially treatable, disorder and prognosis depends on early recognition and prompt immunotherapy. We report a case of anti-N-methyl-D-aspartate receptor encephalitis with atypical age and gender, and a characteristic electroencephalographic pattern that supported the diagnosis."
Our news journalists obtained a quote from the research from Karolinska Institute, "A 66-year-old male presented with psychiatric disturbances and focal seizures with alteration of consciousness, and progressed to a state of akinetic mutism. Auxiliary tests were negative or non-specific for anti-NMDAR encephalitis. Electroencephalographic monitoring revealed a unique pattern; the extreme delta brush. The patient improved with immunotherapy and was asymptomatic at six months of follow-up. Ancillary testing was positive for anti-N-methyl-D-aspartate receptor antibodies. Extreme delta brush is a recently described electroencephalographic pattern presenting in only one third of patients with anti-N-methyl-D-aspartate receptor encephalitis."
According to the news editors, the research concluded: "The identification of this pattern, as in our case, may guide early diagnosis and treatment of anti-N-methyl-D-aspartate receptor encephalitis."
For more information on this research see: Extreme delta brush in a patient with anti-NMDAR encephalitis. Epileptic Disorders, 2013;15(4):461-464. Epileptic Disorders can be contacted at: John Libbey Eurotext Ltd, 127 Ave De La Republique, 92120 Montrouge, France. (Springer - www.springer.com; Epileptic Disorders - www.springerlink.com/content/1950-6945/)
The news correspondents report that additional information may be obtained from D. Di Capua, Karolinska Inst, Dept. of Neurobiol Care Sci & Soc, Div Clin Geriatr, Stockholm, Sweden. Additional authors for this research include S. Garcia-Ptacek, M.E. Garcia-Garcia, B. Abarrategui, J. Porta-Etessam and I. Garcia-Morales (see also Biotechnology).
Keywords for this news article include: Biotechnology, Sweden, Europe, Stockholm, Encephalitis, Immunotherapy, Brain Diseases, Virus Diseases, Immunomodulation, Membrane Proteins, Glutamate Receptors, N-Methyl-D-Aspartate Receptors, Central Nervous System Diseases, Central Nervous System Infections, Central Nervous System Viral Diseases
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC